Increased levels of plasma endothelin-1 in non-insulin dependent diabetic patients with retinopathy but without other diabetes-related organ damage

Increased levels of endothelin (ET-I), a potent endothelium-derived vasoconstrictive peptide, have been found in plasma from noninsulin dependent diabetic (NIDDM) patients, suggesting that ET-I might represent a new marker of diabetes-related vascular damage. To elucidate this topic, circulating ET-1 levels were evaluated in 16 NIDDM patients in good metabolic control without either cardiovascular risk factors (obesity, hypertension, smoking, hyperdislipidaemia, etc.) or diabetes-related damage of other districts and in 12 healthy subjects. Retinopathy was assessed by ophtalmological evaluation and its severity determined by Klein criteria. Resulting data showed higher levels of plasma ET-1 in NIDDM patients than in control subjects (0.80+/-0.13 vs 0.60+/-0.12 pg/mL, p<0.001). Plasma ET-1 levels were directly correlated with retinopathy degrees in NIDDM patients affected by retinopathy (n=10; r=0.368; p=0.02), and were significantly higher in these latter (n=10) than in those without retinopathy (n=6) (0.89+/-0.13 vs 0.71+/-0.19 pg/mL, p<0.05). The increased levels of ET-1 could contribute to retinopathy development or, more probably, represent a marker of this diabetes-related complication.